Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             37 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Angiotensin-converting enzyme inhibitors as a new therapy for atrial fibrillation? Controversy Ogimoto, Akiyoshi
2005
149 3 p. e19-
1 p.
artikel
2 Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention Armstrong, Paul W.
2005
149 3 p. 402-407
6 p.
artikel
3 Association of chronic kidney disease with clinical outcomes after coronary revascularization: The arterial revascularization therapies study (ARTS) Ix, Joachim H.
2005
149 3 p. 512-519
8 p.
artikel
4 Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome: Results of a randomized, double-blind, placebo-controlled study Macin, Stella M.
2005
149 3 p. 451-457
7 p.
artikel
5 Carvedilol therapy is associated with a sustained decline in brain natriuretic peptide levels in patients with congestive heart failure Frantz, Robert P.
2005
149 3 p. 541-547
7 p.
artikel
6 Change of address box 2005
149 3 p. 380-
1 p.
artikel
7 Conducting economic evaluations alongside multinational clinical trials: Toward a research consensus Reed, Shelby D.
2005
149 3 p. 434-443
10 p.
artikel
8 Coronary drug-eluting stent development: Issues in trial design Muni, Neal I.
2005
149 3 p. 415-433
19 p.
artikel
9 Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: The Vytorin Versus Atorvastatin (VYVA) Study Ballantyne, Christie M.
2005
149 3 p. 464-473
10 p.
artikel
10 Early initiation of lipid-lowering therapy for acute coronary syndromes improves compliance with guideline recommendations: Observations from the Orbofiban in Patients with Unstable Coronary Syndromes (OPUS–TIMI 16) trial Smith, Charles S.
2005
149 3 p. 444-450
7 p.
artikel
11 Editorial Board 2005
149 3 p. A6-
1 p.
artikel
12 Electrocardiographic damage scores and cardiovascular mortality Richardson, Kelly
2005
149 3 p. 458-463
6 p.
artikel
13 Exercise treadmill testing using a modified exercise protocol in women with suspected myocardial ischemia: Findings from the National Heart, Lung and Blood Institute–sponsored Women's Ischemia Syndrome Evaluation (WISE) Lewis, Jannet F.
2005
149 3 p. 527-533
7 p.
artikel
14 Influence of clinical trial enrollment on the quality of care and outcomes for patients with non–ST-segment elevation acute coronary syndromes Kandzari, David E.
2005
149 3 p. 474-481
8 p.
artikel
15 Information for Authors 2005
149 3 p. A7-A8
nvt p.
artikel
16 Information for Readers 2005
149 3 p. A10-
1 p.
artikel
17 Is atorvastatin more appropriate to use in combination with niacin than simvastatin in patients with the metabolic syndrome? Al-Shaer, Moutasim H.
2005
149 3 p. e17-
1 p.
artikel
18 Left ventricular systolic asynchrony after acute myocardial infarction in patients with narrow QRS complexes Zhang, Yan
2005
149 3 p. 497-503
7 p.
artikel
19 Letter to the editor Nagge, Jeff
2005
149 3 p. e21-
1 p.
artikel
20 Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients John, Stefan
2005
149 3 p. 473.e1-473.e10
4.729999995271E12 p.
artikel
21 Long-term benefits of an early invasive management in acute coronary syndromes depend on intracoronary stenting and aggressive antiplatelet treatment: A metaregression Biondi-Zoccai, Giuseppe G.L.
2005
149 3 p. 504-511
8 p.
artikel
22 New-onset paroxysmal atrial fibrillation: Is permanence inevitable? Patton, Kristen K.
2005
149 3 p. 388-390
3 p.
artikel
23 Patients with heart failure who die in hospice Zambroski, Cheryl Hoyt
2005
149 3 p. 558-564
7 p.
artikel
24 Plaque regression—A new target for antiatherosclerotic therapy Karha, Juhana
2005
149 3 p. 384-387
4 p.
artikel
25 Prediction of death or myocardial infarction by exercise single photon emission computed tomography perfusion scintigraphy in patients who have had recent coronary artery stenting Rajagopal, Vivek
2005
149 3 p. 534-540
7 p.
artikel
26 Prevalence of anemia and effects on mortality in patients with heart failure Lindenfeld, JoAnn
2005
149 3 p. 391-401
11 p.
artikel
27 Primary stenting of occluded native coronary arteries II—Rationale and design of the PRISON II study: A randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of chronic total coronary occlusions Rahel, Braim M.
2005
149 3 p. 414.e1-414.e3
409861 p.
artikel
28 Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: Results from the Canadian Registry of Atrial Fibrillation Kerr, Charles R.
2005
149 3 p. 489-496
8 p.
artikel
29 Rationale—Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): Evolving the management of cardiovascular risk in patients with chronic kidney disease Mix, T.-Christian H.
2005
149 3 p. 408-413
6 p.
artikel
30 Reducing the costs of phase III cardiovascular clinical trials Eisenstein, Eric L.
2005
149 3 p. 482-488
7 p.
artikel
31 Reply Kruse, Michael W.
2005
149 3 p. e23-e24
nvt p.
artikel
32 Simvastatin does not inhibit intimal hyperplasia and restenosis but promotes plaque regression in normocholesterolemic patients undergoing coronary stenting: A randomized study with intravascular ultrasound Petronio, Anna Sonia
2005
149 3 p. 520-526
7 p.
artikel
33 Statins in acute coronary syndromes: The sooner, the better? Schwartz, Gregory G.
2005
149 3 p. 377-380
4 p.
artikel
34 Statin therapy—Time to turn the focus from efficacy to implementation? Blazing, Michael
2005
149 3 p. 381-383
3 p.
artikel
35 TOC 2005
149 3 p. A2-A5
nvt p.
artikel
36 Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: Results from the Valsartan Heart Failure Trial (Val-HeFT) Maggioni, Aldo P.
2005
149 3 p. 548-557
10 p.
artikel
37 Very early cardiac magnetic resonance imaging for quantification of myocardial tissue perfusion in patients receiving tirofiban before percutaneous coronary intervention for ST-elevation myocardial infarction Steen, Henning
2005
149 3 p. 564.e1-564.e7
5.639994361E9 p.
artikel
                             37 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland